Behavioral Medicine I and II Flashcards Preview

NB 3 Dev & Psych > Behavioral Medicine I and II > Flashcards

Flashcards in Behavioral Medicine I and II Deck (32)
Loading flashcards...
1
Q

list the 5 steps in smoking cessation treatment intervention

A
  1. assessing patient’s readiness to quit
  2. assessing physical dependence
  3. addressing psychological and social determinants
  4. designing a comprehensive treatment strategy
  5. preventing relapse
2
Q

list the series of stages of a patient’s readiness to quit

A
  • precontemplation: initial disinterest in quitting smoking
  • contemplation: thinking about health risks and about quitting
  • preparation: preparing to quit in near future
  • action: currently taking action to stop smoking
  • maintenance: maintaining nonsmoking
3
Q

describe the precontemplation stage in the stages of change model

A
  • peron is not considering change at this point
    • perhaps patient does not see any problem
    • has tried and failed repeatedly and given up
  • health provider’s task:
    • listen empathically to patient
    • educate: increase awareness of risks/benefits
    • raise doubt
4
Q

describe the contemplation stage in the stages of change model

A
  • person is considering quitting but is ambivalent–weighing pros and cons
  • health care provider should:
    • emphasize risks and benefits in relation to person’s medical, psychological and social status
    • help strengthen person’s sense of self-efficacy i.e. the belief that they can do it
    • focus on past “successes” even if short
    • patient vacillation is to be expected
5
Q

describe the preparation stage in the stages of change model

A
  • person intends to take action in near future and has developed a plan of action
  • health care provider should:
    • explore treatment options
    • help set “quit date”
      encourage realistic goals
    • provide support and encouragement
    • consider action-oriented programs
6
Q

describe the action stage in the stages of change model

A
  • person has now made specific modification in lifestyle i.e. has quit smoking
  • health care provider should:
    • help identify high risk situations for return to smoking and help develop coping strategies
    • provide reinforcement–promote confidence and self-efficacy
7
Q

describe the maintenance stage in the stages of change model

A
  • person now able to successfully resist temptation to return to smoking
  • greater confidence
  • able to anticipate risky situations and prepare coping strategies in advance
  • with smoking behavior, relapse is the rule
8
Q
A

preparation

if she was in the contemplation stage, she wouldn’t be ready to set a date; “I’m thinking about quitting, but…”

9
Q

describe indicators of physicial dependence

A
  • the presence of withdrawal symptoms
  • difficulty of previous cessation attempts
  • number of cigarettes smoked daily and their level of nicotine
10
Q

describe why smoking in the morning is an indicator of physical dependence

A
  • physical dependence on nicotine involves some degree of withdrawal during sleeping hours
  • thus, upon awakening there is an increased need for nicotine and it is particularly enjoyable to smoke at this time
11
Q

describe FDA approved products for smoking cessation

A
  • the FDA has approved several nicotine replacement products (NRTs)
    • gum
    • transdermal patch
    • nasal spray
    • vapor inhaler
  • NRTs double long-term cessation rates and relieve withdrawal and craving
12
Q

describe FDA-approved drugs that help with smoking cessation

A
  • sustained release bupropion (Zyban)
    • AD with dopaminergic and noradrenergic activity
  • varenicline (Chantix): partial agonist
    • eases withdrawal by stimulatin nicotine receptors, blocks them if patient takes up smoking again
    • Chantix has been associated with suicidal ideation–banned in 2008 by FAA for use among pilots and air traffic controllers
13
Q

describe psychological and social determinants of smoking

A
  • smoking is a learned behavior
  • cigarettes often become associated with certain events such as social occasions, eating, relaxing, sexual encouters, drinking alcohol, etc.
  • these situational discriminative stimuli trigger the desier to smoke (classical and operant conditioning)
14
Q

describe why smoking is a negative reinforcement

A
  • cigarettes are commonly used to handle stress, anxiety, depression and anger
  • such unpleasant states = internal discriminative stimuli leading to the behavior of smoking
  • smoking tends to relieve such states (negative reinforcement)
15
Q

describe stress management and assertiveness training in smoking cessation

A
  • stress management: many different approahces–progressive muscle relaxation, yoga, meditation, qigong, biofeedback, guided imagery, tai chi, biofeedback, self-hypnosis
  • assertiveness training: designed to help patients resist social pressures to smoke–i.e. to empower them to speak up for themselves and say “no, thanks”
16
Q

describe when NRTs are not recommended

A
  • few withdrawal symptoms
  • relapse > 2 weeks
  • low FTND (Fagerstrom Questionnaire of Nicotine Dependence)
17
Q

describe when NRTs are recommended

A
  • history of withdrawal symptoms
  • relapse < 1 week
  • high FTND
18
Q

describe the different types of therapies for the different types of psychological dependences

A
19
Q

describe social support and therapies

A
20
Q
A

she wants to quit, BUT she is stressed, therefore contemplation

21
Q
A

she is stressed –> relaxation training

she started again because all of her friends smoke –> group therapy needed

FTND low, low physical dependence, quit for a month –> NO NRTs

22
Q

describe the abstinence violation effect (AVE)

A
  • AVE is often seen following unplanned return to use
    • self-blame
    • guilt
    • loss of confidence
  • physician needs to help patient refram this as a “slip” or “lapse” as opposed to a “relapse”
    • “slips are normal and to be expected”
    • “that wasn’t a failure, it was that a short success”
23
Q

describe the weight gain barrier to smoking cessation

A
  • smokers weight 5-10 lb less than nonsmokers
  • when smokers quit, 80% of them gain weight
  • a nicotine-related decrease in metabolic rate and possibly increases in foot intake appear significant
  • weight gain may be a trigger to relapse in some cases
  • clinician response: reassurance that gain won’t be as much as feared; encourage vigorous exercise
24
Q

describe depression as a barrier to smoking cessation

A
  • there is a strong association between smoking and mood disorders
  • depressed smokers are less likely to stop smoking than non-depressed smokers
  • if depression is present, it should be treated before cessation is attempted
25
Q

describe substance abuse as a barrier to smoking cessation

A
  • there is a high rate of smoking among users of alcohol, cocaine and heroin
  • even among smokers who do not abuse alcohol, drinking is commonly associated with smoking relapse
26
Q

describe social support as a barrier to smoking cessation

A
  • smokers with nonsmoking spouses are more likely to be successful in quitting
  • smokers whose efforts to quit are supported by significant others and friends have greater success
    • involving significant others in treatment is beneficial
  • group therapy: good source of support
27
Q

describe motivational interviewing (MI)

A
  • theory of reactance: people are strongly motivated to maintain a sense of autonomy and to resist and defend their behavior when criticized
  • MI is based on the premise that it is much better to build on the patient’s self-motivation to change
  • MI involves an interview style emphasizing empathy, curiosity, self-determination and acceptance
28
Q

name the 4 main principles of motivational interviewing

A
  • roll with the resistance
  • develop discrepancy
  • express empathy
  • enhance self-efficacy
29
Q

describe the method of roll with the resistance during MI

A
  • expect resistance: it’s natural–change is difficult
  • don’t fight against it: flow with it
  • patient must come to own conclusion that it’s best to change–goal is not to impose new view/goal
  • the “righting reflex”: it can be difficult for the clinician to resist telling patient she/he is doing something wrong and to resort to direct persuasion
30
Q

describe the method of “develop discrepancy” during MI

A
  • the patient is stuck and needs your help to move along
  • help patient see the discrepancy between where they want to be and where they are now
  • if they accept your invitation of assistance it will be becuase of their own reasons
31
Q

describe the method of “express empathy” during MI

A
  • accept patients for who they are–judging or blaming is counterproductive
    • this does not necessarily imply condoning their behavior
  • the paralyzing ambivalence clinicians see in their patients with regard to changing health behaviors that appear to clearly damaging can be better understood through clinician self-reflection and self-awareness
32
Q

describe the method of “enhace self-efficacy” during MI

A
  • “self-efficacy” (self-confidence) is critical for behavior change
    • you’ve got to believe you can do it
  • be supportive, get creative–help patient see what a difference behavior change will make in her life